Merck Sees 2005 Profit Hurt by Vioxx Merck  amp; Co. Inc.(MRK), reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of \$2.42 to \$2.52 a share -- a decline from expected 2004 results.